Two-day versus seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial.
Messous S, Trabelsi I, Bel Haj Ali K, Abdelghani A, Ben Daya Y, Razgallah R, Grissa MH, Beltaief K, Mezgar Z, Belguith A, Bouida W, Boukef R, Boubaker H, Msolli MA, Sekma A, Nouira S.
Messous S, et al. Among authors: trabelsi i.
Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666221099729. doi: 10.1177/17534666221099729.
Ther Adv Respir Dis. 2022.
PMID: 35657073
Free PMC article.
Clinical Trial.